focus
Previous article:
Drug repurposing or repositioning? The language matters
Next article: Eli Lilly’s Zepbound improved liver scarring in mid
Next article: Eli Lilly’s Zepbound improved liver scarring in mid
explore
focus
-
CMS got Medicare Advantage quality rating wrong, judge rules
2025-09-30 17:04 -
FDA approves Moderna’s RSV vaccine, its second licensed product
2025-09-30 17:01 -
Health care court cases: Humana, Sutter, Novant
2025-09-30 16:50 -
Moderna says combo Covid
2025-09-30 16:27 -
CMS got Medicare Advantage quality rating wrong, judge rules
2025-09-30 16:26 -
Novartis is flashing warning signs about its newly acquired myelofibrosis drug
2025-09-30 15:24